A diagnostic pathogenic mutation was found in 3 patients in the SCN1A, STXBP1 and SCN4A, who clinically were diagnosed with Dravet syndrome, Lennox-Gastaut syndrome, paramytonia and seizures respectively. This evidence concerns the gene SCN4A and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.